We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Sandra and Edward Meyer Cancer Center

Warning message

The subscription service is currently unavailable. Please try again later.

You are here

News

An Interventional Approach to Pancreatic Cancer

Friday, December 14, 2018

From the Weill Cornell Medicine Newsroom:

Being diagnosed with advanced metastatic pancreatic cancer was a grim experience for Steve Price. But thanks to his doctors at Weill Cornell Medicine and NewYork-Presbyterian, state-of-the-art interventional radiology allowed him to receive chemotherapy immediately after biopsy, shrinking his tumors dramatically. Then, a precision medicine clinical trial revealed that Price had a mutation in the BRCA1 gene, normally associated with breast cancer. By examining his unique genetic profile, Price’s medical team was able to determine that a new therapy targeting the mutation could give him his life back.